Google
 
Google

World Stem Cell Summit 2010

Wednesday, July 29, 2009

Cord Blood America (OTC BB: CBAI) CEO Matthew Schissler Discusses Company's New Stem Cell Lab in Las

Release #:812-68650-em-434148:

Cord Blood America (OTC BB: CBAI) CEO Matthew Schissler Discusses Company's New Stem Cell Lab in Las Vegas

Cord Blood America CEO Discusses Reasons for New, Large Stem Cell Laboratory

SANTA MONICA, Calif. and LAS VEGAS, July 30 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), one of the largest umbilical cord blood stem cell preservation companies (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, emphasized that the Company's new stem cell laboratory in Las Vegas will allow it to significantly diversify its revenue stream.

The entire interview is available at http://www.stoxrox.com/cbai-7-29-09.mp3

Cord Blood America recently announced it is opening a state-of-the-art laboratory, one of the largest in the U.S., for the storage of multiple stem cell products, including adipose tissue, peripheral blood stem cells and umbilical cord blood stem cells. "The lab will allow Cord Blood to store new sources of stem cells, greatly increasing our competitive advantage," Mr. Schissler said in the interview. "We believe that more and more uses for stem cells in treating diseases are going to be found, making their storage even more valuable."

Cord Blood America's CEO also emphasized that the new lab reduces the cost of storing stem cells for the company and allows it to begin a research and development program and to seek government and other grants.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

 

        CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com 

 


My EANDE

More Information


Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time